Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase (NCT02258607) | Sierra Oncology LLC - a GSK company | 2015-03-11 |
Track Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.